Molecular pathways of nonalcoholic fatty liver disease development and progression

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2018-10-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00018-018-2947-0PMID 30343320PMCID PMC11105781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients

  2020cited by this paper
• The natural course of non-alcoholic fatty liver disease

  2020cited by this paper
• Formation of p62‐positive inclusion body is associated with macrophage polarization in non‐alcoholic fatty liver disease

  2018cited by this paper
• Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view

  2018cited by this paper
• Adiponectin: A potential therapeutic target for metabolic syndrome.

  2018cited by this paper
• The hedgehog pathway in nonalcoholic fatty liver disease

  2018cited by this paper
• Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis

  2017cited by this paper
• Genetic predisposition in nonalcoholic fatty liver disease

  2017cited by this paper
• Matrix metalloproteinases and liver fibrosis (translational aspects).

  2017cited by this paper
• Nonalcoholic steatohepatitis is associated with a state of betaine‐insufficiency

  2017cited by this paper
• Mitogen-activated protein kinases are involved in hepatocanalicular dysfunction and cholestasis induced by oxidative stress

  2017cited by this paper
• Nonobese Fatty Liver Disease

  2017cited by this paper
• Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children

  2017cited by this paper
• Cytosolic lipolysis and lipophagy: two sides of the same coin

  2017cited by this paper
• Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

  2017cited by this paper
• Insights into the Hexose Liver Metabolism—Glucose versus Fructose

  2017cited by this paper
• Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism

  2017cited by this paper
• Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity

  2017cited by this paper
• Role of Hedgehog Signaling Pathway in NASH

  2016cited by this paper
• CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.

  2016cited by this paper
• Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum.

  2016cited by this paper
• Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis[S]

  2016cited by this paper
• Function of Autophagy in Nonalcoholic Fatty Liver Disease

  2016cited by this paper
• A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism

  2016cited by this paper
• TGF‐β signalling and liver disease

  2016cited by this paper
• Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice.

  2016cited by this paper
• Sonic hedgehog signaling in hepatocellular carcinoma: A pilot study

  2016cited by this paper
• Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome*

  2016cited by this paper
• Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

  2016cited by this paper
• Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

  2016cited by this paper
• Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis.

  2016cited by this paper
• Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

  2016cited by this paper
• Sonic hedgehog signaling pathway mediates development of hepatocellular carcinoma

  2016cited by this paper
• Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis

  2015cited by this paper
• PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis

  2015cited by this paper
• Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis

  2015cited by this paper
• Ceramides - Lipotoxic Inducers of Metabolic Disorders.

  2015cited by this paper
• Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism

  2015cited by this paper
• Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease

  2015cited by this paper
• The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update

  2015cited by this paper
• Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

  2015cited by this paper
• Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

  2015cited by this paper
• Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.

  2015cited by this paper
• Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

  2015cited by this paper
• Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

  2015cited by this paper
• Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine

  2015cited by this paper
• Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.

  2015cited by this paper
• Free Fatty Acids Shift Insulin-induced Hepatocyte Proliferation towards CD95-dependent Apoptosis*

  2014cited by this paper
• ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload

  2014cited by this paper
• Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD

  2014cited by this paper
• Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion

  2014cited by this paper
• Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers

  2014cited by this paper
• The Ca2+-calmodulin-Ca2+/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes

  2014cited by this paper
• Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue.

  2014cited by this paper
• Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation.

  2014cited by this paper
• Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.

  2014cited by this paper
• Gli2 silencing enhances TRAIL-induced apoptosis and reduces tumor growth in human hepatoma cells in vivo

  2014cited by this paper
• Abnormality of autophagic function and cathepsin expression in the liver from patients with non‐alcoholic fatty liver disease

  2014cited by this paper
• Immunohistochemical study of the autophagy marker microtubule‐associated protein 1 light chain 3 in normal and steatotic human livers

  2014cited by this paper
• CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance.

  2014cited by this paper
• CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.

  2014cited by this paper
• Autophagy: A novel therapeutic target for hepatocarcinoma (Review)

  2014cited by this paper
• Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.

  2014cited by this paper
• Mechanism linking diabetes mellitus and obesity

  2014cited by this paper
• CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis

  2013cited by this paper
• Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo

  2013cited by this paper
• Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

  2013cited by this paper
• Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation*

  2013cited by this paper
• TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells.

  2013cited by this paper
• The Metabolic Burden of Methyl Donor Deficiency with Focus on the Betaine Homocysteine Methyltransferase Pathway

  2013cited by this paper
• Mechanisms of insulin resistance in obesity

  2013cited by this paper
• Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice.

  2013cited by this paper
• Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP

  2013cited by this paper
• Unfolded Protein Response Signaling and Metabolic Diseases*

  2013cited by this paper
• Puma, a critical mediator of cell death — one decade on from its discovery

  2012cited by this paper
• Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.

  2012cited by this paper
• Role of oxidative stress and molecular changes in liver fibrosis: a review.

  2012cited by this paper
• Central role of mitochondria in drug-induced liver injury

  2012cited by this paper
• Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis

  2012cited by this paper
• Iron Metabolism in Nonalcoholic Fatty Liver Disease

  2012cited by this paper
• Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine

  2012cited by this paper
• Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.

  2012cited by this paper
• Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

  2012cited by this paper
• Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?

  2012cited by this paper
• Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress

  2012cited by this paper
• Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.

  2012cited by this paper
• Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

  2012cited by this paper
• Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis.

  2012cited by this paper
• The epidemiology, pathogenesis and histopathology of fatty liver disease

  2012cited by this paper
• The Autophagy-related Gene 14 (Atg14) Is Regulated by Forkhead Box O Transcription Factors and Circadian Rhythms and Plays a Critical Role in Hepatic Autophagy and Lipid Metabolism*

  2012cited by this paper
• Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

  2012cited by this paper
• NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development

  2012cited by this paper
• A hedgehog survival pathway in 'undead' lipotoxic hepatocytes.

  2012cited by this paper
• Palmitate and Lipopolysaccharide Trigger Synergistic Ceramide Production in Primary Macrophages*

  2012cited by this paper
• Effect of RhoA on transforming growth factor β1‐induced rat hepatic stellate cell migration

  2012cited by this paper
• Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

  2011cited by this paper
• Kaerophyllin inhibits hepatic stellate cell activation by apoptotic bodies from hepatocytes

  2011cited by this paper
• Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

  2011cited by this paper
• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

  2011cited by this paper
• Functions of autophagy in hepatic and pancreatic physiology and disease.

  2011cited by this paper

• Inflammation burden index as a complementary marker for the assessment of hepatic steatosis and fibrosis: evidence from NHANES 2017-2018.

  2026cites this paper
• Simultaneous quantification of sphingolipid metabolites in human plasma using UPLC-MS/MS.

  2026cites this paper
• Exploring Recent Insights on Intermittent Fasting in Regulating Glucocorticoid Levels and Diet-Induced Metabolic Disorders with Focus on MAFLD and Hepatic Outcomes.

  2026cites this paper
• Study on the effect and mechanism of Ershiyiwei Lvronghao concentrated Pills in the treatment of nonalcoholic fatty liver disease

  2026cites this paper
• Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised rats

  2026cites this paper
• Black Sesame Pigment Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the Gut-Liver Axis and HIF-1 Signaling Pathway.

  2026cites this paper
• Nanoemulsion of coriander oil and Asparagus racemosus extract enhances immunity in Nile tilapia (Oreochromis niloticus).

  2026cites this paper
• Meta-analysis of the effectiveness of fecal microbiota transplantation in the treatment of metabolic-associated fatty liver disease: A systematic review based on liver inflammation indicators and fat content

  2026cites this paper
• TM6SF2 in Hepatic Lipid Metabolism and Chronic Liver Disease

  2026cites this paper
• Mechanisms of lipid metabolic disorder and inflammation in the clam Ruditapes philippinarum under PAHs stress.

  2026cites this paper
• Serum PCBs, OCPs, PBDEs and PCAs: Associations with metabolic syndrome risk factors in the Flemish Gut Flora Project cohort.

  2026cites this paper
• Xanthine oxidoreductase activity in MASLD: links to lipid metabolism, oxidative stress, and inflammation

  2026cites this paper
• Skrining SGOT dan SGPT sebagai Deteksi Dini Gangguan Fungsi Hati untuk Peningkatan Kualitas Hidup

  2026cites this paper
• Transcriptomic Changes Underlying the Anti-Steatotic Effects of DHA Supplementation in Aged Obese Female Mice

  2025cites this paper
• Strategies for developing dual-targeted soluble epoxide hydrolase inhibitors.

  2025cites this paper
• Monascus pilosus SWM‐008–Fermented Red Mold Rice and Its Monascinol Ameliorate Non‐Alcoholic Fatty Liver Disease via Activation of the AMPK–ATGL Pathway and Enrichment of Butyrate‐Producing Bacteria

  2025cites this paper
• Evaluation of 0.55T MRI for Simultaneous R2* and Fat Fraction Quantification in the Presence of Hepatic Iron Overload and Steatosis Using Simulations and Phantoms

  2025cites this paper
• Benzo[a]pyrene exposure increases inflammation, lipid accumulation, and lipid metabolism disfunction in the clam Ruditapes philippinarum.

  2025cites this paper
• Lipid-lowering mechanism of Swietenia macrophylla King leaves through SREBP-1c/FASN axis and RNA sequencing validation

  2025cites this paper
• Regulatory Role of Nuclear Factor of Activated T Cells c4 in the Development of Metabolic dysfunction-associated Fatty Liver Disease

  2025cites this paper
• Investigating multimorbidity trajectories in people living with MASLD diagnosis: A trajectory analysis using the UK Biobank

  2025cites this paper
• A review of the phytochemical and pharmacological properties of FlosLoniceraeJaponicae in treating obesity and type 2 diabetes mellitus: a medicinal and edible plant

  2025cites this paper
• Nitroxoline mitigates hepatic steatosis by enhancing cholesterol efflux and promoting bile acid synthesis through LRH-1 signaling

  2025cites this paper
• Metabolic syndrome components as determinants of NAFLD progression in Bangladesh: a cross-sectional study

  2025cites this paper
• Induction of lipid autophagy by chitosan-coated selenium nanoparticles mitigates NAFLD in vitro and in vivo.

  2025cites this paper
• Modulation of inflammatory signaling by vitamin E metabolites and its therapeutic implications

  2025cites this paper
• Appropriate dietary phosphorus levels promote growth performance, mineral retention, and hepatic lipid metabolism in juvenile American eels (Anguilla rostrata)

  2025cites this paper
• Analysis of factors affecting early hepatic steatosis in pediatric patients with Wilson’s disease in China: A retrospective study

  2025cites this paper
• Lipidomic and Transcriptomic Reveals Variations in Lipid Deposition During Goose Fatty Liver Formation

  2025cites this paper
• Reference genes for quantitative real-time polymerase chain reaction in in vitro non-alcoholic fatty liver disease.

  2025cites this paper
• Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges

  2025cites this paper
• INHIBITION OF THE PROSTAGLANDIN-DEGRADING ENZYME 15-PGDH AMELIORATES MASH-ASSOCIATED APOPTOSIS AND FIBROSIS IN MICE

  2025cites this paper
• Flavonoid Polyphenols as Therapeutic Agents for Fatty Liver Disease: Mechanisms, Microbiome Interactions, and Metabolic Insights

  2025cites this paper
• Ferroptosis as a potential therapeutic target for obesity-related metabolic diseases

  2025cites this paper
• β-Alanine alleviated non-alcoholic fatty liver disease via regulation of hepatic sulfur-amino acid metabolism in mice

  2025influential citation
• Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: A meta-analysis of randomized controlled trials.

  2025cites this paper
• Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet-induced steatotic liver disease.

  2025cites this paper
• Therapeutic potential of fisetin in hepatic steatosis: Insights into autophagy pathway regulation and endoplasmic reticulum stress alleviation in high-fat diet-fed mice

  2025cites this paper
• Is UA/HDL-C a Reliable Surrogate Marker for Fatty Liver? A Comparative Evaluation with Metabolic Scores in a Mexican Population: The Genetics of Atherosclerotic Disease Study

  2025cites this paper
• Thai Kratom extracts ameliorate MAFLD through multi-target mechanism in FFA-induced HepG2 cells

  2025cites this paper
• Targeted therapeutic strategies as alternative and sustainable treatment options for obesity-induced steatohepatitis

  2025cites this paper
• Unravelling the mechanisms of Erchen decoction in the treatment of nonalcoholic fatty liver disease (NAFLD): an integrative study combining network pharmacology, molecular docking, molecular dynamics simulation, multi-omics analysis, and experimental validation.

  2025cites this paper
• Pharmacological Treatment of MASLD: Contemporary Treatment and Future Perspectives

  2025cites this paper
• Oxidative stress and caspase 3/Gsdme-dependent pyroptosis contributes to high fat diet induced-intestinal inflammation and lipotoxicity via Srebp1 cleavage at D444 site by caspase 3.

  2025cites this paper
• Protective role of geraniol in high fat diet-induced NAFLD: balancing lipid homeostasis, antioxidant defence, and inflammatory responses.

  2025cites this paper
• Clinical features of COVID-19 in hospitalized patients with non-alcoholic fatty liver disease

  2025cites this paper
• Vagotomy improves brown adipose tissue morphology and reduces steatosis in obese mice.

  2025cites this paper
• Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool

  2025cites this paper
• Modulation of molecular and serological biomarkers by (-)-epicatechin consumption on a murine model of metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Causal Relationship Between Genetically Determined Free Fatty Acids and Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study

  2025cites this paper
• Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998–2020

  2025cites this paper
• Detoxification metabolic pathways and hepatotoxicity mechanisms of B[a]P in reproductive clam Ruditapes philippinarum.

  2025cites this paper
• Multi-omics reveals the mechanism of Trimethylamine N-oxide derived from gut microbiota inducing liver fatty of dairy cows

  2025cites this paper
• BefA protein alleviates progression of non-alcoholic fatty liver disease by modulating the AMPK signaling pathway through the gut-liver axis.

  2025cites this paper
• Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017–2020

  2025cites this paper
• Adipokines regulate the development and progression of MASLD through organellar oxidative stress

  2025cites this paper
• Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma

  2025cites this paper
• Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities

  2025cites this paper
• Perfluorooctane sulfonate induces hepatotoxicity through promoting inflammation, cell death and autophagy in a rat model.

  2025cites this paper
• The Paraoxonase (PON) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other Diseases

  2025cites this paper
• Hepatic fat fraction and lipid content of adrenal adenomas: insights from unenhanced CT.

  2025cites this paper
• Association of Epigenetic Aging Biomarkers With Risk of MASLD‐Related HCC

  2025cites this paper
• Weissella viridescens Attenuates Hepatic Injury, Oxidative Stress, and Inflammation in a Rat Model of High-Fat Diet-Induced MASLD

  2025cites this paper
• Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• GSK621 ameliorates lipid accumulation via AMPK pathways and reduces oxidative stress in hepatocytes in vitro and in obese mice in vivo.

  2025cites this paper
• Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)

  2025cites this paper
• Combined Esculentin-2CHa Fusion Protein-Coated Au Nanoparticles for Effective Against Non-Alcoholic Fatty Liver Disease in Mice Model

  2025cites this paper
• An oligosaccharide isolated from Rosa canina ameliorates lipid profile and liver damage in MASLD modeled rabbits: in vivo and in silico studies

  2025cites this paper
• The Chronobiological and Neuroprotective Mechanisms of Resveratrol in Improving Sleep

  2025cites this paper
• Bulk transcriptome and single-nucleus RNA sequencing analyses highlight the role of recombination activating 1 in non-alcoholic fatty liver disease.

  2025cites this paper
• Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases

  2025cites this paper
• Lactiplantibacillus plantarum FRT4 protects against fatty liver hemorrhage syndrome: regulating gut microbiota and FoxO/TLR-4/NF-κB signaling pathway in laying hens

  2025cites this paper
• TRIB3 Is a Hub Gene in Steatohepatitis and Aggravates Lipid Deposition and Inflammation in Hepatocytes

  2025cites this paper
• Causal Relationships between Iron Status and Nonalcoholic Fatty Liver Disease: Two-Sample, Multivariable, and Two-Step Mendelian Randomization.

  2025cites this paper
• Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis

  2025cites this paper
• Proteomics and Phosphoproteomics Revealed Dysregulated Kinases and Potential Therapy for Liver Fibrosis

  2025cites this paper
• Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease

  2025cites this paper
• High fat diet (HFD) induced hepatic lipogenic metabolism and lipotoxicity via Parkin-dependent mitophagy and Errα signal of Pelteobagrus fulvidraco

  2025cites this paper
• BMDM-derived ORP8 suppresses lipotoxicity and inflammation by relieving endoplasmic reticulum stress in mice with MASH

  2025cites this paper
• Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective

  2025influential citation
• Vitamin D and MAFLD: a bibliometric and visual analysis from 2007 to 2024

  2025cites this paper
• A study on the impact of polycyclic aromatic hydrocarbons (PAHs) on the risk of liver disease in middle-aged and older adults people based on the CHARLS database.

  2025cites this paper
• MicroRNA: A Novel Class of Potential Biomarkers and Therapeutic Target for Non-Alcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

  2025cites this paper
• КЛИНИКО-ЛАБОРАТОРНАЯ ХАРАКТЕРИСТИКА ТЕЧЕНИЯ COVID-19 У ГОСПИТАЛИЗИРОВАННЫХ ПАЦИЕНТОВ С НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНЬЮ ПЕЧЕНИ

  2025cites this paper
• Ganoderma Sinense Soluble Dietary Fiber Alleviates Nonalcoholic Fatty Liver Disease by Regulating Liver Metabolism

  2025cites this paper
• Heat stroke-induced hepatic lipid dysregulation: histological and lipidomic insights.

  2025cites this paper
• Recent advances in anterior pituitary hormones and metabolic-associated fatty liver disease

  2025cites this paper
• Global, regional and national burden of Metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15–49 years from 1990 to 2021: results from the 2021 Global Burden of Disease study

  2025cites this paper
• Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity

  2025cites this paper
• Recent advances in the treatment of non-alcoholic fatty liver disease with astragaloside IV

  2025cites this paper
• AISI and MASLD: a nonlinear association in U.S. adults (NHANES 2017-2020)

  2025cites this paper
• The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

  2025cites this paper
• Induction of Autophagy as a Therapeutic Breakthrough for NAFLD: Current Evidence and Perspectives

  2025cites this paper
• Divergent Hepatic and Adipose Tissue Effects of Kupffer Cell Depletion in a Male Rat Model of Metabolic-Associated Steatohepatitis

  2025cites this paper
• Coenzyme Q and Selenium Co-Supplementation Alleviate Methionine Choline-Deficient Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Mice

  2025cites this paper
• Remnant cholesterol and its variability independent of low density lipoprotein cholesterol predict metabolic dysfunction associated steatotic liver disease

  2025cites this paper
• Matcha Green Tea Improves Cafeteria-Diet-Induced NAFLD by Modulating the Gut Microbiota in Rats

  2025cites this paper
• MyD88 orchestrates fatty acid metabolism in tumor-associated macrophages and non-alcoholic fatty liver disease-related hepatocarcinogenesis

  2025cites this paper
• The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular Carcinoma

  2025cites this paper
• The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies

  2025cites this paper